Citadel Sees Most U.S. Staff Returning to the Office by June 1 (Bloomberg) Ken Griffin’s Citadel expects to have most of its U.S. employees back in...
Keep Reading →
May 4 - Hedge Funds, Insider Trading - Comments
Today we are going to take a look at the 10 easiest countries to adopt a child. Click to skip our introduction and methodology and jump to the 5 Easiest...
Keep Reading →
April 20 - Lists, News - Comments
In this article we will evaluate the 20 most unhealthiest countries in the world. You can skip our comprehensive discussion of these countries and go...
Keep Reading →
April 16 - Lists, News - Comments
In this article we will take a look at the 10 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical industry’s outlook...
Keep Reading →
March 25 - Hedge Funds, News - Comments
In this article we discuss the 5 best pharma stocks to buy now. If you want to read our detailed analysis of the pharma industry, go directly to 10 Best...
Keep Reading →
March 25 - Hedge Funds, News - Comments
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter,...
Keep Reading →
March 22 - Hedge Funds, News - Comments
Below we present the list of Top 5 Large-Cap Healthcare Stocks to Buy Now. For our methodology and a more comprehensive look at Henrik Rhenman’s Rhenman...
Keep Reading →
February 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
Eli Lilly and Co. (NYSE:LLY) was founded by a pharmacist named Colonel Eli Lilly way back in 1876. The company, known for its quality drugs, is often...
Keep Reading →
February 4 - Earnings Report, News - Comments
Eli Lilly’s ‘Antibody Therapy’ showed great results after series of clinical trials as its sales went on an upward spree caused by the...
Keep Reading →
February 3 - Market Movers, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Keep Reading →
December 8 - Hedge Funds, News - Comments
Below we’ll check out the Top 5 Stocks New Mets Owner Steve Cohen Was Buying in Q3. For more background on the billionaire investor and a look at some...
Keep Reading →
November 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
In this article, we present the 15 states with the highest diabetes rates in the U.S. Click to skip ahead and see the 5 states with the highest diabetes...
Keep Reading →
September 16 - Lists, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Keep Reading →
August 31 - Hedge Funds, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Keep Reading →
July 7 - Hedge Funds, News - Comments
Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter, a copy of which you can download here. The Amana Income Fund posted a return of...
Keep Reading →
June 17 - Hedge Fund Investor Letters, News - Comments
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows...
Keep Reading →
May 30 - Hedge Funds, News - Comments
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market...
Keep Reading →
May 4 - Hedge Funds, News - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Keep Reading →
March 12 - News - Comments
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
Keep Reading →
December 25 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook...
Keep Reading →
November 28 - Hedge Funds, News - Comments
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first...
Keep Reading →
October 10 - Hedge Funds, News - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Keep Reading →
June 7 - Hedge Funds, News - Comments
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors...
Keep Reading →
March 26 - Hedge Funds, News - Comments
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Keep Reading →
December 9 - Hedge Funds, News - Comments
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government. The 13F filings show...
Keep Reading →
November 13 - Hedge Funds, News - Comments
Insiders are masters of snatching up shares of their companies at a discount, expanding their positions during weakness in the stock. In contrast, they...
Keep Reading →
June 18 - Insider Trading, Market Movers, News - Comments
The five opioid treatment stocks are among several companies that have taken their own approach to the growing opioid addiction market in the US, which...
Keep Reading →
February 5 - Lists, News - Comments
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from...
Keep Reading →
December 14 - Lists, News - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest...
Keep Reading →
November 24 - News - Comments
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in. These...
Keep Reading →
July 17 - Dividend Stocks, News - Comments
1. US Stock Market: “U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while...
Keep Reading →
April 17 - Commodities, Gold, Market Movers, News, Tech - Comments
The 10 least obese countries in the world are mostly from Asia and Africa. Changing food habits, improving medical care and awareness about one’s health...
Keep Reading →
March 26 - Lists, News - Comments
Detailed results from the IXORA-S study have revealed that Taltz (ixekizumab) has superior efficacy compared to Stelara (ustekinumab). According to Eli...
Keep Reading →
March 8 - News, Stock Analysis - Comments
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system....
Keep Reading →
February 23 - News, Stock Analysis - Comments
The once per week Trulicity label from Eli Lilly and Co (NYSE:LLY) has been updated. The changes, which have been approved by the U.S. Food and Drug Administration...
Keep Reading →
February 9 - News, Stock Analysis - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE...
Keep Reading →
January 24 - News, Stock Analysis - Comments
Eli Lilly and Co (NYSE:LLY) just announced that it is set to acquire junior biotech CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) in a deal worth up to $960...
Keep Reading →
January 19 - News, Stock Analysis - Comments
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and...
Keep Reading →
January 17 - Lists, News - Comments
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences...
Keep Reading →
December 23 - News, Stock Analysis - Comments
AstraZeneca plc (ADR) (NYSE:AZN) has recently unveiled how it plans to transform its US Commercial segment as part of its broader growth strategy. “...
Keep Reading →
December 9 - News, Stock Analysis - Comments
Eli Lilly and Co (NYSE:LLY) has recently confirmed that it will cut jobs following the release of disappointing results from a clinical trial evaluating...
Keep Reading →
December 8 - News, Stock Analysis - Comments
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Co (NYSE:LLY) are yet again the subject of immense criticism as their practice of increasing the prices of key...
Keep Reading →
November 29 - News, Stock Analysis - Comments
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors...
Keep Reading →
November 27 - Hedge Funds, News - Comments
As the markets take a break for Thanksgiving, things settled down a little bit late-Wednesday, but not before some sharp shocks in the biotech sector....
Keep Reading →
November 24 - Market Movers, News, Stock Analysis - Comments
Biogen Inc (NASDAQ:BIIB) stock is getting whacked in sympathy to Eli Lilly and Co (NYSE:LLY)‘s announcement that it has once again failed in its...
Keep Reading →
November 23 - News, Stock Analysis - Comments
Eli Lilly And Co (NYSE:LLY) is having an incredibly rough day in the market today. After starting the day off in the red, the stock has fallen further...
Keep Reading →
November 23 - News, Stock Analysis - Comments
On the day before Thanksgiving, five stocks, First Solar, Inc. (NASDAQ:FSLR), Medtronic PLC (NYSE:MDT), Eli Lilly and Co (NYSE:LLY), Axovant Sciences...
Keep Reading →
November 23 - News - Comments
Becton Dickinson (BD) has recently unveiled BD U-500 Insulin Syringe, a syringe dedicated to the Humulin R U-500 insulin of Eli Lilly and Co (NYSE:LLY...
Keep Reading →
November 10 - News, Stock Analysis - Comments
Eli Lilly and Co (NYSE:LLY) has categorically stated to its regulators and investors that it is hanging onto a possible nod from the FDA for a new indication...
Keep Reading →
November 2 - News, Stock Analysis - Comments
Although his family office isn’t technically a hedge fund anymore (a settlement with the SEC saw to that), many on Wall Street still regard billionaire...
Keep Reading →
September 19 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News - Comments
